Insider · CIK 0001574075
Kenneth J. Kencel
Files at NCDL (Nuveen Churchill Direct Lending Corp.), Nuveen Churchill Private Capital Income Fund. First filing Nov 6, 2023, latest Sep 30, 2026.
In brief
Kenneth J. Kencel files SEC Form 4 as CEO, president and director at NCDL (Nuveen Churchill Direct Lending Corp.), and also at Nuveen Churchill Private Capital Income Fund. Since Nov 6, 2023, Kenneth J. Kencel has reported 9 open-market buys worth $2.3M and 0 open-market sells worth $0, the latest filed on Sep 30, 2026.
After Kenneth J. Kencel's past buys, the stock trailed the S&P 500 by a median 10.9% over six months (n = 6), and 0% of those buys were ahead of the index at six months. InsiderTell labels that a negative record.
The newest scored trade: bought $500k of Nuveen Churchill Private Capital Income Fund on Sep 28, 2026, filed Sep 30, 2026, scored 53 (moderate). In the last 12 months: 4 buys worth $1.0M and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NCDL: Nuveen Churchill Direct Lending Corp.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | -buy Nuveen Churchill Private Capital Income Fund | $500k 20,964 shares | +416% | - | |
| 71Notable | Nuveen Churchill Direct Lending Corp. | $130k 10,000 shares | +21% | +1% from low-19% from high | |
| 71Notable | Nuveen Churchill Direct Lending Corp. | $130k 10,000 shares | +36% | +1% from low-19% from high | |
| 74Notable | Nuveen Churchill Direct Lending Corp. | $284k 20,000 shares | +71% | +6% from low-15% from high | |
| 73Notable | Nuveen Churchill Direct Lending Corp. | $249k 16,234 shares | +81% | +5% from low-12% from high | |
| 46Moderate | -buy Nuveen Churchill Private Capital Income Fund | $250k 10,085 shares | - | - | |
| 63Notable | Nuveen Churchill Direct Lending Corp. | $347k 20,000 shares | +200% | - | |
| 56Moderate | Nuveen Churchill Direct Lending Corp. | $347k 20,000 shares | - | - | |
| 45Moderate | Nuveen Churchill Direct Lending Corp. | $55k 3,033 shares | +16% | - |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | - Nuveen Churchill Private Capital Income Fund | POpen-market purchase Class Iindirect: By Trust | +10,482 | $23.85 | $250k | 15,525 | 13 d ago |
| Sep 28, 2026 | - Nuveen Churchill Private Capital Income Fund | POpen-market purchase Class Iindirect: By Wife's Trust | +10,482 | $23.85 | $250k | 15,525 | 13 d ago |
| Mar 3, 2026 | NCDL Nuveen Churchill Direct Lending Corp. | POpen-market purchase Common Stockindirect: By Trust | +10,000 | $13.04 | $130k | 58,117 | Mar 5, 2026 |
| Mar 3, 2026 | NCDL Nuveen Churchill Direct Lending Corp. | POpen-market purchase Common Stockindirect: By Spouse | +10,000 | $13.04 | $130k | 38,117 | Mar 5, 2026 |
| Nov 6, 2025 | NCDL Nuveen Churchill Direct Lending Corp. | POpen-market purchase Common Stockindirect: By Trust | +20,000 | $14.22 | $284k | 48,117 | Nov 7, 2025 |
| May 12, 2025 | NCDL Nuveen Churchill Direct Lending Corp. | POpen-market purchase Common Stockindirect: By Spouse | +8,117 | $15.34 | $124k | 28,117 | May 13, 2025 |
| May 12, 2025 | NCDL Nuveen Churchill Direct Lending Corp. | POpen-market purchase Common Stockindirect: By Trust | +8,117 | $15.34 | $124k | 28,117 | May 13, 2025 |
| Dec 31, 2024 | - Nuveen Churchill Private Capital Income Fund | POpen-market purchase Class Iindirect: By Trust | +5,042 | $24.79 | $125k | 5,042 | Jan 2, 2025 |
| Dec 31, 2024 | - Nuveen Churchill Private Capital Income Fund | POpen-market purchase Class Iindirect: By Wife's Trust | +5,042 | $24.79 | $125k | 5,042 | Jan 2, 2025 |
| Dec 2, 2024 | NCDL Nuveen Churchill Direct Lending Corp. | POpen-market purchase Common Stockindirect: By Spouse | +10,000 | $17.37 | $174k | 20,000 | Dec 3, 2024 |
| Dec 2, 2024 | NCDL Nuveen Churchill Direct Lending Corp. | POpen-market purchase Common Stockindirect: By Trust | +10,000 | $17.37 | $174k | 20,000 | Dec 3, 2024 |
| Nov 27, 2024 | NCDL Nuveen Churchill Direct Lending Corp. | POpen-market purchase Common Stockindirect: By Spouse | +10,000 | $17.35 | $174k | 10,000 | Dec 2, 2024 |
| Nov 27, 2024 | NCDL Nuveen Churchill Direct Lending Corp. | POpen-market purchase Common Stockindirect: By Trust | +10,000 | $17.35 | $174k | 10,000 | Dec 2, 2024 |
| Nov 3, 2023 | NCDL Nuveen Churchill Direct Lending Corp. | POpen-market purchase Common Stockindirect: Joint Account | +3,033 | $18.19 | $55k | 22,473 | Nov 6, 2023 |
Questions about Kenneth J. Kencel
Answered from the filings on this page, as of the latest one.
Is Kenneth J. Kencel buying or selling?
In the last 12 months Kenneth J. Kencel reported 4 open-market buys worth $1.0M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $500k of Nuveen Churchill Private Capital Income Fund on Sep 28, 2026. Grants, option exercises and tax withholding are not counted.
How did Kenneth J. Kencel's past buys perform?
Measured from the first close after each filing, the stock trailed the S&P 500 by a median 10.9% over six months across 6 past buys, with 0% ahead of the index. Past results describe what happened; they do not predict the next trade.
Where does Kenneth J. Kencel file Form 4?
Kenneth J. Kencel has filed Form 4 at NCDL (Nuveen Churchill Direct Lending Corp.) as CEO & President; Nuveen Churchill Private Capital Income Fund as CEO and President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.